Á¦11ȸ ¼¿ï´ëÇб³ ¾Ï¿¬±¸¼Ò ¾Ï ½ÉÆ÷Áö¿ò Novel Molecular Targets for Cancer Therapy (»ï¼º ¾Ï¿¬±¸µ¿ °³°ü 2Áֳ⠱â³ä) [ÃÊûÀÇ ¸»¾¸] ¼¿ï´ëÇб³ ¾Ï¿¬±¸¼Ò´Â 1963³â¿¡ ¼³¸³µÇ¾î ±¹³» ÇаèÀÇ À¯¼öÇÑ ¾Ï¿¬±¸ÀÚµéÀÌ ¸ð¿© ±¤¹üÀ§Çϸ鼵µ ÁýÁßÀûÀÎ ¿¬±¸¸¦ Áö¼ÓÇØ¿Â ¾ÏÀü¹® ¿¬±¸±â°üÀ¸·Î¼, 1992³âºÎÅÍ Á¤±âÀûÀÎ ¾Ï ½ÉÆ÷Áö¿òÀ» °³ÃÖÇϱ⠽ÃÀÛÇÏ¿©, ¿ÃÇØ·Î Á¦ 11ȸ¸¦ ¸ÂÀÌÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ º» ¿¬±¸¼ÒÀÇ »ï¼º ¾Ï¿¬±¸µ¿Àº »ï¼º±×·ìÀÇ Áö¿øÀ» ¹Þ¾Æ 1997³â¿¡ ±â°øÇÏ¿© 2000³â 3¿ù °³¼ÒÇÔÀ¸·Î½á, ¾Ï¿¬±¸¸¦ À§ÇÑ µ¶ÀÚÀûÀÎ °ø°£°ú ÃֽŠ¼³ºñ¸¦ ¿ÏºñÇÏ¿´À¸¸ç, ¿ÃÇØ·Î °³°ü 2ÁÖ³âÀ» ¸ÂÀÌÇÏ°Ô µÇ¾ú½À´Ï´Ù. À̹ø Á¦ 11ȸ ¾Ï ½ÉÆ÷Áö¿ò¿¡¼´Â "Novel Molecular Targets for Cancer Therapy" ¸¦ ÁÖÁ¦·Î ÇÏ¿© 4¿ù 26-27ÀÏ ¾çÀÏ°£ ¾ÏÄ¡·á¸¦ À§ÇÑ »õ·Î¿î ºÐÀÚÇ¥Àû¹°ÁúÀÇ ¹ß±¼¿¡ ´ëÇÑ ÃֽŠÁö°ßÀ» ³íÀÇÇÏ°íÀÚ ÇÕ´Ï´Ù. ƯÈ÷, º» ½ÉÆ÷Áö¿ò¿¡¼´Â »õ·Î¿î °³³äÀÇ Ç×¾ÏÁ¦ STI571 °³¹ßÀÚÀÎ Zimmerman ¹Ú»ç¿Í angiogenesisÀÇ ¼¼°èÀû ±ÇÀ§ÀÚÀÎ Semenza ¹Ú»ç µî ±¹³»¿ÜÀÇ Àú¸íÇÑ ¾Ï¿¬±¸ÀÚµéÀ» ÃÊ´ëÇÏ¿© ÃÖ±Ù ¿¬±¸ÇöȲ°ú ÇâÈÄÀÇ Àü¸ÁÀ» ¸ð»öÇÏ´Â ÇмúȸÀÇ°¡ µÉ ¼ö ÀÖµµ·Ï ÇÏ¿´½À´Ï´Ù. ¾Ï¿¬±¸¿¡ Á¾»çÇϽô ¿©·¯ºÐ¿¡°Ô À¯ÀÍÇÑ ½Ã°£ÀÌ µÉ °ÍÀ¸·Î È®½ÅÇÏ¸ç ºÎµð ¸¹Àº ºÐÀÌ Âü¼®ÇϽþî È°¹ßÇÑ Åä·ÐÀ» ºÎŹµå¸®°Ú½À´Ï´Ù. 2002³â 3¿ù ¾Ï¿¬±¸¼ÒÀå ¹æ ¿µ ÁÖ
[Âü°¡ ½Åû] * Âü°¡ºñ´Â »çÀüµî·Ï 2¸¸¿ø, ´çÀϵî·Ï 3¸¸¿øÀÔ´Ï´Ù. * »çÀüµî·Ï¸¶°¨Àº 4¿ù 20ÀÏÀ̸ç FAX 02-766-4477 ¶Ç´Â ¼¿ï´ëÇб³ ¾Ï¿¬±¸¼Ò ȨÆäÀÌÁö http://cri.snu.ac.kr ¸¦ ÅëÇÏ¿© µî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù. * »çÀüµî·Ï½Ã ½ÅûÀÎÀÇ ¼º¸íÀ» ÇÊÈ÷ ±âÀÔÇÏ½Ã°í ¾Æ·¡ÀÇ ÀºÇà°èÁ·ΠÀԱݽÃÄÑ ÁֽʽÿÀ.
¿¹±ÝÁÖ: ¹æ¿µÁÖ Á¶ÈïÀºÇà ¿¬°Çµ¿ ÁöÁ¡ ±¸Á¹øÈ£: 367-04-682033 ------------------------------------------------------------------------------------- Novel Molecular Targets for Cancer Therapy ÀϽà : 4¿ù 26ÀÏ(±Ý)-27ÀÏ(Åä) Àå¼Ò : ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¾Ï¿¬±¸µ¿ 2Ãþ ÀÌ°ÇÈñȦ April 26th (Fri), 2002 - Opening ceremony 9:00-9:30 - Molecular imaging and therapy of cancer using radionuclide Kyung-Han Lee (Sungkyunkwan Univ., Korea) 9:30-9:55 Radiotracer methods and gene expression monitoring Uwe Haberkorn (Heidelberg Univ. Germany) 9:55-10:35 Monitoring of gene transfer and therapy using radionuclide June-Key Chung (Seoul National Univ., Korea) 10:35-11:00 Molecular imaging using sodium/iodide symporter gene Ronald Blasberg (Memorial Sloan Kettering Hosp., USA) 11:00-11:40 Imaging of endogenous molecular events and signal transduction pathway - Lunch 12:00-13:00 - Lecture-I : Gregg L. Semenza (Johns Hopkins Univ., USA) 13:00-13:50 Regulation of tumor angiogenesis and metastasis by hypoxia-inducible factor 1 - Targeting metastasis / angiogenesis Motoharu Seiki (Univ. of Tokyo, Japan) 14:00-14:40 Roles of membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis Kyu-Won Kim (Seoul National Univ., Korea) 14:40-15:05 HBx functions as a novel angiogenic activator by modulating hypoxic protein interaction networks - Coffee Break 15:05-15:20 - Regulation of gene expression Seong-Jin Kim (National Cancer Inst., USA) 15:20-16:00 Regulation of gene expression by histone acetyltransferase and deacetylase Yun Gyu Park (Korea Univ., Korea) 16:00-16:25 Gene-specific inhibition of tumor growth by CRE-decoy oligonucleotide Masa-aki Ikeda (Tokyo Medical & Dental Univ., Japan) 16:25-17:05 Role of the p300 transcription coactivator in suppression of epithelial tumor growth Tae-You Kim (Seoul National Univ., Korea) 17:05-17:30 Novel targets of histone deacetylase inhibitor April 27th (Sat), 2002 - Targeting differentiation / cell cycle Satoshi Miyake (Tokyo Medical & Dental Univ., Japan) 09:00-09:40 Regulation of transcription by a novel family of differentiation inhibitor Deug Y. Shin (Dankook Univ., Korea) 09:40-10:05 New anti-cancer drugs design for targeting of cell cycle checkpoint mechanism Piortr Sicinski (Harvard Medical School, USA) 10:05-10:45 Cyclins in mouse development and in cancer - Lecture-II : Zuerg Zimmermann (Norvatis Co., Switzerland) 10:45-11:35 Glivec - a new treatment modality for CML. A case history. - Targeting apoptotic pathway Eui-Ju Choi (Korea Univ., Korea) 11:35-12:00 Identification of a novel anti-apoptotic protein that antagonizes the JNK/SAPK pathway and CAD activity Hidenori Ichijo (Tokyo Medical & Dental Univ., Japan) 12:00-12:40 Regulation of stress-induced cell death by the ASK1-MAP kinase cascade - Closing Remarks 12:40-12:50
|